Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaolin Ma

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Oncogene|July 11, 2019
Identifying and targeting angiogenesis-related microRNAs in ovarian cancerXiuhui Chen, Lingegowda S Mangala, Linda Mooberry, et al.
Molecular Cancer Therapeutics|March 31, 2019
GnRH-R-Targeted Lytic Peptide Sensitizes <i>BRCA</i> Wild-type Ovarian Cancer to PARP InhibitionShaolin Ma, Sunila Pradeep, Alejandro Villar-Prados, et al.
Cell Reports|February 10, 2021
Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotypeShaolin Ma, Michael H McGuire, Lingegowda S Mangala, et al.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|August 4, 2022
[Expert statement on the construction criteria of critical care department in municipal and district designated hospitals under the pandemic prevention and control]Ruilan Wang, Jiao Liu, Ke Ma, et al.
Molecular Cancer Therapeutics|November 14, 2018
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4Alejandro Villar-Prados, Sherry Y Wu, Karem A Court, et al.
Molecular Cancer Therapeutics|September 29, 2021
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse ModelsKatelyn F Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, et al.
Cell Reports|August 18, 2021
CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistanceShaolin Ma, Lingegowda S Mangala, Wen Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR ExpressionHeather J Dalton, Sunila Pradeep, Michael McGuire, et al.
Cell Reports|December 7, 2017
Differential Effects of EGFL6 on Tumor versus Wound AngiogenesisKyunghee Noh, Lingegowda S Mangala, Hee-Dong Han, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Oncogene|July 11, 2019
Identifying and targeting angiogenesis-related microRNAs in ovarian cancerXiuhui Chen, Lingegowda S Mangala, Linda Mooberry, et al.
Molecular Cancer Therapeutics|March 31, 2019
GnRH-R-Targeted Lytic Peptide Sensitizes <i>BRCA</i> Wild-type Ovarian Cancer to PARP InhibitionShaolin Ma, Sunila Pradeep, Alejandro Villar-Prados, et al.
Cell Reports|February 10, 2021
Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotypeShaolin Ma, Michael H McGuire, Lingegowda S Mangala, et al.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|August 4, 2022
[Expert statement on the construction criteria of critical care department in municipal and district designated hospitals under the pandemic prevention and control]Ruilan Wang, Jiao Liu, Ke Ma, et al.
Molecular Cancer Therapeutics|November 14, 2018
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4Alejandro Villar-Prados, Sherry Y Wu, Karem A Court, et al.
Molecular Cancer Therapeutics|September 29, 2021
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse ModelsKatelyn F Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, et al.
Cell Reports|August 18, 2021
CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistanceShaolin Ma, Lingegowda S Mangala, Wen Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR ExpressionHeather J Dalton, Sunila Pradeep, Michael McGuire, et al.
Cell Reports|December 7, 2017
Differential Effects of EGFL6 on Tumor versus Wound AngiogenesisKyunghee Noh, Lingegowda S Mangala, Hee-Dong Han, et al.
Pageof 6